Medication info
Allyga Soft Capsule 10mg (Alitretinoin)

Allyga Soft Capsule 10mg (Alitretinoin)

Prescription medicationSoft capsuleOral
Ingredient · strength
Alitretinoin›10mg / 1 capsule
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
Brown oval soft capsule containing a uniform yellow to yellow-green liquid
Packaging
Box - 30 capsules/box [10 capsules/PTP*3]
Approval status
Active

MFDS item code 201907205 · Approved 2019.10.14 · Insurance code 641607080

Summary

Main use
Treatment of chronic severe hand eczema in adults that does not respond to potent topical corticosteroids
Who takes it
Adults
Adult dose
Take 10~30mg once daily with or immediately after a meal. It is preferable to take it at the same time each day. The initial dose is 30mg of alitretinoin; reduce to 10mg depending on adverse reactions. Patients with diabetes, obesity, cardiovascular risk factors, or dyslipidemia: The initial dose is 10mg and may be increased to 30mg if necessary, depending on tolerability and effect. Periodic monitoring of the blood lipid profile and blood glucose may be necessary during treatment with this medicine. Discontinue treatment as soon as the treatment goal of clear or almost clear hands is achieved. If hand eczema remains severe after the initial 12 weeks of treatment, discontinue treatment. Also discontinue treatment if the treatment goal has not been achieved by week 24.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of chronic severe hand eczema in adults that does not respond to potent topical corticosteroids

  • Chronic severe hand eczema
View approved original text

This medication is used to treat chronic severe hand eczema in adults that does not improve with at least 4 weeks of potent topical steroid treatment.

How to take

Adult dose

Take 10~30mg once daily with or immediately after a meal. It is preferable to take it at the same time each day. The initial dose is 30mg of alitretinoin; reduce to 10mg depending on adverse reactions. Patients with diabetes, obesity, cardiovascular risk factors, or dyslipidemia: The initial dose is 10mg and may be increased to 30mg if necessary, depending on tolerability and effect. Periodic monitoring of the blood lipid profile and blood glucose may be necessary during treatment with this medicine. Discontinue treatment as soon as the treatment goal of clear or almost clear hands is achieved. If hand eczema remains severe after the initial 12 weeks of treatment, discontinue treatment. Also discontinue treatment if the treatment goal has not been achieved by week 24.

Precautions

This medication should never be used by women who are pregnant or may become pregnant due to the high risk of causing severe congenital malformations in the fetus. Pregnancy tests must be conducted before starting and during treatment, and two effective methods of contraception should be used concurrently. If pregnancy occurs during treatment or within 1 month after treatment, there is a significant risk to the fetus, so caution is needed. Very high serum triglyceride levels can lead to severe side effects such as acute pancreatitis, so blood lipid levels should be regularly tested and managed. If symptoms of pancreatitis appear, discontinue use immediately. It is recommended that this medication be prescribed by a specialist with experience in systemic retinoid therapy, and it should not be administered to patients with severely impaired liver or kidney function, uncontrolled thyroid function, hypervitaminosis A, or certain allergies. Patients with mental health issues or a history of depression should be closely monitored for symptoms of depression, mood changes, or suicidal thoughts while taking this medication, and appropriate treatment should be sought if necessary. This medication may cause various side effects such as skin dryness, headache, flushing, dry eyes, vision changes, gastrointestinal symptoms, etc., so if any abnormal symptoms occur, consult a doctor immediately. Increased sensitivity to ultraviolet rays may occur, so excessive sun exposure or phototherapy should be avoided, and sunscreen should be used. Taking this medication concurrently with other vitamin A preparations or tetracycline antibiotics can be risky, so it is important to inform your doctor or pharmacist about any medications you are taking. All parties involved - doctors, pharmacists, and patients - must receive strict management and education according to the pregnancy prevention program, and this medication should not be shared or given to others. Serious side effects may occur with overdose, so it is essential to adhere to the prescribed dosage and duration, and the capsules should be taken with water after meals and not chewed. This medication should be stored in a cool place out of reach of children and away from direct sunlight, and expired medications should not be taken.

Side effects

  • Headache
  • erythema
  • flushing
  • increased triglycerides
  • increased cholesterol
  • decreased thyroid-stimulating hormone
  • decreased free T4
  • anemia
  • increased iron-binding capacity
  • decreased monocytes
Show 62 more
  • increased platelets
  • anaphylaxis
  • hypersensitivity reactions
  • depression
  • mood changes
  • suicidal ideation
  • dizziness
  • benign intracranial hypertension
  • conjunctivitis
  • dry eyes
  • eye irritation
  • blurred vision
  • cataract
  • decreased night vision
  • tinnitus
  • hypertension
  • vasculitis
  • nosebleeds
  • nausea
  • dry mouth
  • vomiting
  • indigestion
  • inflammatory bowel disease
  • increased aminotransferases
  • dry skin and lips
  • cheilitis
  • eczema
  • dermatitis
  • hair loss
  • pruritus
  • rash
  • skin peeling
  • dry eczema
  • nail disorders
  • photosensitivity reactions
  • hair texture abnormalities
  • arthralgia
  • myalgia
  • osteitis
  • ankylosing spondylitis
  • fatigue
  • peripheral edema
  • hypertriglyceridemia
  • decreased HDL
  • hypercholesterolemia
  • increased serum creatine phosphokinase
  • diabetes mellitus
  • color blindness
  • intolerance to contact lenses
  • early epiphyseal closure
  • hyperostosis
  • calcification of ligaments and tendons
  • corneal opacification
  • keratitis
  • inflammatory bowel disease
  • skin allergic reactions
  • anaphylaxis
  • purpura
  • severe allergic vasculitis
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that prevents light exposure. Additionally, the medication should be kept in a temperature range of 1 to 30 degrees Celsius, avoiding extremely hot or cold environments.

Appearance and packaging

Appearance

Brown oval soft capsule containing a uniform yellow to yellow-green liquid

Package unit

Box - 30 capsules/box [10 capsules/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.